Yahoo
Shenzhen - Delayed Quote CNY

Shandong Xinhua Pharmaceutical Company Limited (000756.SZ)

12.63 -0.12 (-0.94%)
At close: November 6 at 3:04:03 PM GMT+8
View in AlphaSpace Currency in CNY All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
8,052,930.99
8,754,721.99
8,466,309.80
8,100,844.71
7,502,987.10
Cost of Revenue
6,571,860.62
7,110,179.63
6,424,760.72
5,709,142.35
5,465,656.11
Gross Profit
1,481,070.37
1,644,542.36
2,041,549.08
2,391,702.36
2,037,330.99
Operating Expense
1,115,866.29
1,202,993.88
1,445,217.88
1,779,508.91
1,493,907.88
Operating Income
365,204.07
441,548.48
596,331.20
612,193.44
543,423.11
Net Non Operating Interest Income Expense
-60,134.60
-36,797.86
-31,233.27
-31,771.75
-42,552.81
Pretax Income
266,103.52
358,916.50
533,653.42
532,685.73
471,774.35
Tax Provision
32,853.16
52,612.59
46,938.85
26,578.70
45,664.57
Net Income Common Stockholders
228,711.13
289,888.86
470,023.75
496,512.20
411,063.06
Basic EPS
0.33
0.42
0.69
0.74
0.62
Diluted EPS
0.33
0.42
0.68
0.72
0.61
Basic Average Shares
693,281.83
690,211.56
681,193.84
670,962.43
663,004.93
Diluted Average Shares
693,281.83
690,211.56
691,211.39
689,600.28
673,873.86
Total Operating Income as Reported
276,469.99
363,984.85
534,370.67
534,582.01
476,706.53
Total Expenses
7,687,726.92
8,313,173.51
7,869,978.61
7,488,651.27
6,959,563.99
Net Income from Continuing & Discontinued Operation
228,711.13
289,888.86
470,023.75
496,512.20
411,063.06
Normalized Income
263,531.58
333,204.08
524,432.84
563,820.94
449,957.03
Interest Income
7,220.36
7,685.44
11,125.52
12,300.49
10,462.01
Interest Expense
38,902.16
42,431.33
39,739.28
41,148.59
49,706.94
Net Interest Income
-60,134.60
-36,797.86
-31,233.27
-31,771.75
-42,552.81
EBIT
305,005.69
401,347.83
573,392.70
573,834.31
521,481.29
EBITDA
305,005.69
988,865.54
1,114,337.88
1,090,772.37
1,010,884.74
Reconciled Cost of Revenue
6,571,860.62
7,110,179.63
6,424,760.72
5,709,142.35
5,465,656.11
Reconciled Depreciation
557,392.78
587,517.71
540,945.18
516,938.06
489,403.45
Net Income from Continuing Operation Net Minority Interest
228,711.13
289,888.86
470,023.75
496,512.20
411,063.06
Total Unusual Items Excluding Goodwill
-39,724.89
-50,755.30
-59,656.32
-70,843.52
-43,062.09
Total Unusual Items
-39,724.89
-50,755.30
-59,656.32
-70,843.52
-43,062.09
Normalized EBITDA
344,730.57
1,039,620.84
1,173,994.20
1,161,615.89
1,053,946.84
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-4,904.44
-7,440.08
-5,247.22
-3,534.78
-4,168.12
12/31/2022 - 8/6/1997

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: